source
- CMS proposes rule to slash Medicare 340B drug payments by over a thirdCMS announced a proposed rule that would reduce the rates Medicare uses to reimburse hospitals for drugs purchased through the 340B program. The reduction would be more than one-third, effectively…
- Cancer and immune-focused biotech firms capture over $3.9 billion of H1 2026 venture capitalBioPharma Dive data show that cancer and immune disease biotech companies accounted for more than 40% of the biotech firms receiving venture funding in the first half of 2026. Of the roughly $9 bi…